Royce & Associates’s STAAR Surgical STAA Stock Holding History
Bought
Maintained
Sold
Other funds holding STAA
BC
AIM
JSP
PAI
GCM
Royce & Associates's STAA Position: Q3 2023 in Review
Royce & Associates sold out of STAAR Surgical (STAA) in Q3 2023, closing a stake of 18,618 shares — an estimated $979K sold.
Royce & Associates first reported a position in STAA in Q4 2013 and held it in 19 quarters. The position peaked at $9.28M in Q3 2020. 217 funds tracked by Wall St. Rank hold STAA as of Q3 2023.
- Royce & Associates reported no remaining STAAR Surgical position as of Q3 2023 after selling out during the quarter.
- Royce & Associates sold 18,618 STAAR Surgical shares in Q3 2023, an estimated $979K.
- Royce & Associates first reported a position in STAAR Surgical in Q4 2013 and held it in 19 quarters.
- Royce & Associates's STAAR Surgical position peaked at $9.28M in Q3 2020.
- 217 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2023.
Based on Royce & Associates's 13F filing for Q3 2023, filed 9 Nov 2023.